Pemetrexed for the first-line treatment of non-small-cell lung cancer

  • Technology appraisal guidance
  • TA181
  • Published: 
Download guidance (PDF)

7 Review of guidance

7.1 The guidance on this technology was reviewed in January 2012. Details are on the NICE website.

Andrew Dillon
Chief Executive
September 2009